Combined oral contraceptive interference with the ability of ulipristal acetate to delay ovulation: A prospective cohort study. [PDF]
Contraception, 2018 Edelman AB +5 more
europepmc +1 more source
Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial. [PDF]
Acta Obstet Gynecol Scand, 2020 de Milliano I +8 more
europepmc +1 more source
Video counseling about emergency contraception: an observational study. [PDF]
Contraception, 2019 Sanders JN +4 more
europepmc +1 more source
Pharmacy access to Ulipristal acetate in major cities throughout the United States. [PDF]
Contraception, 2018 Shigesato M +6 more
europepmc +1 more source
Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial. [PDF]
Obstet Gynecol, 2019 Lukes AS +6 more
europepmc +1 more source
Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur? [PDF]
Womens Health (Lond), 2017 Odejinmi F, Oliver R, Mallick R.
europepmc +1 more source
Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix. [PDF]
Int J Mol Med, 2018 Shin SJ +6 more
europepmc +1 more source
Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study. [PDF]
J Ovarian Res, 2018 Czuczwar P +4 more
europepmc +1 more source